MedTrace Logo

Antiperistaltic Effect and Safety of L-menthol in the Elderly With Contraindication to Buscopan

NCT04593836 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-10-20

No results posted yet for this study

Summary

antiperistaltic effect and safety of L-menthol versus placebo for upper GI endoscopy in elderly patient with contraindication to Buscopan: randomized study

Conditions

  • Upper Gastrointestinal Endoscopy

Interventions

DRUG

L-menthol

20ml 0.8% L-menthol spray on the pyloric ring and observe the gastric peristalsis

DRUG

Placebo

20ml 0.8% placebo spray on the pyloric ring and observe the gastric peristalsis

Sponsors & Collaborators

  • Taipei Veterans General Hospital, Taiwan

    lead OTHER_GOV

Principal Investigators

  • Ming-Chih Hou, MD · Taipei Veterans General Hospital, Taiwan

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04593836 on ClinicalTrials.gov